Ammonium Chloride for COVID-19: real-time analysis of 2 studies

Ammonium Chloride for COVID-19

1 study with 120 patients

Control

Ammonium Chloride Serious Outcome Risk

Significantly lower risk for recovery.

COVID-19 Ammonium Chloride studies. Mar 2026. c19early.org

Recent:


Mar 8	Maltezou et al., Research Square, doi:10.21203/rs.3.rs-9009421/v1	Effectiveness of a sustained-release ammonium chloride formulation in reducing the viral load of patients with COVID-19 or influenza: A prospective, randomized, double-blind, placebo-controlled study
	RCT 32 outpatients (28 with COVID-19) showing potential virological benefit with ammonium chloride. All participants experienced mild illness with no progression to severe disease, hospitalization, or death in either cohort. There was a s..
Jul 31 2021	Siami et al., International Journal of Infectious Diseases, doi:10.1016/j.ijid.2021.04.043	Effect of Ammonium Chloride in addition to standard of care in outpatients and hospitalized COVID-19 patients: A randomized clinical trial
	202% higher mortality (p=0.2), 8% lower ventilation (p=0.9), and 65% improved recovery (p=0.003). RCT 120 COVID-19 patients showing no significant difference in mortality but improved recovery time and reduced viral burden with ammonium chloride treatment.